Panelist: Innovations in Psychedelics, Funding and the Future
Top universities are opening psychedelic research centers and investors are funding innovation in the private sector. The pace of change is rapid. What does the emerging landscape look like and what should we be most excited and cautious about regarding the evolution of psychedelic medicines and therapies? Hear perspectives from leaders in the space about the evolving science and business of psychedelics.
More About Julie
Julie Holland, MD is a renowned psychiatrist and psychopharmacologist, a medical advisor to the Multidisciplinary Association for Psychedelic Studies (MAPS) and was previously the medical monitor for several clinical studies examining the efficacy of using MDMA-assisted psychotherapy or cannabis in the treatment of Post Traumatic Stress Disorder. Dr. Holland has a large private psychopharmacology practice, has worked for decades on US drug policy reform, and is a New York Times bestselling author.